Financial statements Notes to the consolidated financial statements continued 6.
Profit for the year continued On 12 May 2016  LLP was appointed and replaced Deloitte LLP.
The Group auditors remuneration on a worldwide basis was as below: 2016 2015 $m $m Audit of the Companys annual accounts 0.6 0.4 Audit of the Companys subsidiaries pursuant to legislation 1.6 1.2 Total audit fees 2.2 1.6 Assurance services 0.2 0.1 Total audit and assurance fees 2.4 1.7 - Tax compliance services 0.1 - Tax advisory services 0.6 0.3 - Other services 2.5 Total non-audit fees 0.6 2.9 Total fees 3.0 4.6 Assurance services relate to review procedures in respect of the interim financial information.
Other services include transaction services, in particular relating to West-Ward Columbus prospectus class one circular.
A description of the work of the Audit Committee is set out in the Audit Committee report on pages 84 to 90 and includes an explanation of how auditor objectivity and independence is safeguarded when non-audit services are provided by the auditor.
Staff costs The average monthly number of employees including Executive Directors was: 2016 2015 Number Number Production 4,904 3,896 Sales and marketing 2,147 2,164 General and administrative 992 865 Research and development 296 264 8,339 7,189 2016 2015 $m $m Their aggregate remuneration comprised: Wages, salaries and bonuses 320 247 Social security costs 29 22 Post-employment benefits 16 7 End of service indemnity 6 14 Share-based payments note 38 22 15 Car and housing allowances 17 19 Health insurance 32 19 Other costs and employee benefits 23 19 465 362 Hikma Pharmaceuticals PLC 168 160 Hikma Pharmaceuticals plc
